Cargando…
ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma
BACKGROUND: Tumor metastasis is the major reason for poor prognosis of hepatocellular carcinoma (HCC) patients after hepatic resection. SMYD3 has been demonstrated to promote liver tumor metastasis in mice. However, the detailed molecular mechanism is still largely unknown. METHODS: The effect of SM...
Autores principales: | Zhou, Zhenyu, Jiang, Hai, Tu, Kangsheng, Yu, Wei, Zhang, Jianlong, Hu, Zhigang, Zhang, Heyun, Hao, Dake, Huang, Pinbo, Wang, Jie, Wang, Aijun, Xiao, Zhiyu, He, Chuanchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332640/ https://www.ncbi.nlm.nih.gov/pubmed/30646949 http://dx.doi.org/10.1186/s13046-018-1011-0 |
Ejemplares similares
-
SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent manner
por: Lv, Hong-Wei, et al.
Publicado: (2021) -
Epithelial-Mesenchymal Transition is Superior to Vessels-Encapsulate Tumor Cluster in Promoting Metastasis of Hepatocellular Carcinoma: a Morphological Evidence
por: He, Chuanchao, et al.
Publicado: (2017) -
SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters
por: Zhang, Heyun, et al.
Publicado: (2021) -
Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters
por: Zhang, Heyun, et al.
Publicado: (2021) -
Uridine-cytidine kinase 2 promotes metastasis of hepatocellular carcinoma cells via the Stat3 pathway
por: Zhou, Qiming, et al.
Publicado: (2018)